The study can provide useful information to interventional cardiologists performing PCI with new-generation DES in AMI patients, regarding the importance of hyperglycemia (especially prediabetes) and the relationship with worse cardiovascular outcomes after both high intensity and low-moderate-intensity statin treatment
The study can provide useful information to interventional cardiologists performing PCI with new-generation DES in AMI patients, regarding the importance of hyperglycemia (especially prediabetes) and the relationship with worse cardiovascular outcomes after both high intensity and low-moderate-intensity statin treatment
The 60th European Association for the Study of Diabetes (EASD) Annual Meeting held on September 9-13, 2024 in Madrid. The EASD Annual Meeting provided the perfect setting to exchange ideas and network with peers from all over the world, connecting the global diabetes community, sharing groundbreaking diabetes science and research, and offering educational opportunities.
The world’s leading cardiology experts convened in London, UK and online at the European Society of Cardiology 2024 congress (ESC 2024, 30 August – 2 September). ESC 2024 aimed to transform patient care and advance the field through ground-breaking research, pioneering technologies, and collaborative initiatives.
From June 21–24, the American Diabetes Association (ADA) hosted the 84th Scientific Sessions in Orlando, FL. The ADA’s Scientific Sessions is the world’s largest diabetes meeting, convening more than 11,000 leading physicians, scientists, researchers and health care professionals from around the globe. The leading diabetes scientific sessions meeting presented groundbreaking data on key topics including Obesity, Technology, AI Health and the latest in diabetes innovation.
